Asian Spectator

Men's Weekly

.

Ozempic(R)Superior in Lowering Blood Sugar and Weight Vs Place...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
BAGSVÆRD, Denmark, March 5, 2019 /PRNewswire-AsiaNet/ -- Novo Nordisk today announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology. The objective of this 30 week trial was to assess the efficacy and safety of Ozempic(R) (semaglutide) 1.0 mg when add...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Buying Managed IT Services in Australia (Without Paying for Surprises)

Managed IT usually becomes a serious conversation when interruptions start affecting delivery. For most Australian businesses in the 7–100 staff range, that shift happens quietly.  For example, clo...

Ramadan jadi peluang ‘brand’ melejit: Intip strategi Marjan, Promag, dan sarung Atlas

● Ramadan secara tradisi mendorong terjadinya peningkatan konsumsi masyarakat yang cukup signifikan.● Karena itu, Ramadan kerap dijadikan momen untuk meningkatkan omzet bagi brand.● ...

4 ribu ASN dijadikan komponen cadangan: Keharusan atau militerisasi?

Seorang prajurit TNI membawa peluru kaliber saat mengikuti latihan militer di Jawa Timur.Lonewolfgher_06/Shutterstock● Pelibatan ASN sebagai Komponen Cadangan dapat merusak supremasi sipil.χ...